THIS ISSUE
You can make an impact
“Positively Aware saved my life.”
Facing COVID in prison while living with HIV
A recently released inmate looks at the effects of quarantine—and stigma
Straight, living with HIV, and invisible
“HIV don’t care if you are black or white, or straight or gay.” —Eunice Marshall
PrEPared?
As long-acting treatment and prevention begins to enter communities, we must move toward dismantling systemic racism
The challenge of diagnosing HIV in people on long-acting PrEP
Impressive results from two efficacy trials of a long-acting form of the integrase inhibitor cabotegravir (CAB LA) have boosted prospects for long-acting HIV pre-exposure prophylaxis (PrEP). In both cases, CAB LA proved superior to oral Truvada PrEP (see table below).
‘Folks who need the most should get the most’
PACHA appointee Tori Cooper discusses the needs of the transgender community with PA associate editor Enid Vázquez
Transforming power
The transgender community takes the reins
EVERY ISSUE
Editor's Note Nov+Dec 2021
Communities left behind
Briefly Nov+Dec 2021
Long-acting PrEP with cabotegravir could be around the corner
Positively Aging: Measuring isolation and loneliness
There are a number of ways to look at support
Being Bridgette
As a woman
SPECIAL SECTION - A DAY WITH HIV
Everyday moments in extraordinary lives
24-hour period in the lives of people affected by HIV